Takeda Pharmaceutical (TAK) Current Assets: 2018-2025

Historic Current Assets for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $16.6 billion.

  • Takeda Pharmaceutical's Current Assets fell 4.28% to $16.5 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $16.5 billion, marking a year-over-year decrease of 4.28%. This contributed to the annual value of $16.6 billion for FY2025, which is 6.71% down from last year.
  • Takeda Pharmaceutical's Current Assets amounted to $16.6 billion in FY2025, which was down 6.71% from $17.7 billion recorded in FY2024.
  • Takeda Pharmaceutical's 5-year Current Assets high stood at $25.6 billion for FY2021, and its period low was $16.6 billion during FY2025.
  • Its 3-year average for Current Assets is $17.3 billion, with a median of $17.7 billion in 2024.
  • Its Current Assets has fluctuated over the past 5 years, first rose by 12.64% in 2021, then declined by 23.16% in 2023.
  • Takeda Pharmaceutical's Current Assets (Yearly) stood at $25.6 billion in 2021, then decreased by 9.73% to $23.1 billion in 2022, then dropped by 23.16% to $17.8 billion in 2023, then decreased by 0.05% to $17.7 billion in 2024, then declined by 6.71% to $16.6 billion in 2025.